1. Organophosphorus compounds that produce a delayed neurotoxic effect in hens phosphorylate a specific site in the brain soon after administration. 2. Phosphorylation of the specific site by di-isopropyl [32P]phosphorofluoridate in vitro is blocked by the prior addition of phenyl phenylacetate. 3. A small proportion of the total activity of hen brain hydrolysing phenyl phenylacetate in vitro was shown to be due to an enzyme different from two others previously described. 4. This enzyme is only slightly inhibited in vitro by concentrations of tetraethyl pyrophosphate and paraoxon (diethyl 4-nitrophenyl phosphate) up to 64 pM and is completely inhibited by 6,uM-di-isopropyl phosphorofluoridate and 128 ltM-mipafox. 5. It is also inhibited in vivo by effective doses of neurotoxic organophosphorus compounds but not by high doses of non-neurotoxic analogues. 6. It is deduced that the active site of this enzyme is the phosphorylation site associated with the genesis of delayed neurotoxicity.
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The delayed neurotoxic effect produced by some organophosphorus compounds appears 8-14 days after dosing, but an early event in hens has been shown to be phosphorylation of a site in nervous tissue within a few hours of dosing. The site was identified in vitro by selective labelling with [32P]DFP* (Johnson, 1969) . In this method two identical tissue samples were preincubated in media containing TEPP (16,uM) , one of which also contained mipafox (128,UM); many possible [32P]DFPlabelling sites were removed by phosphorylation with TEPP, and mipafox also phosphorylated the neurotoxic site. After preincubation the samples were incubated under identical conditions with [32P]DFP and the difference between labelling of macromolecules in the two samples was a measure of the site.
Studies reported in this paper are based on the proposal that if a compound capable of forming a complex with the site were added to the medium just before [32P] DFP then phosphorylation and labelling of the site would be prevented. I chose to investigate esters in this role since the phosphorylation site is probably a protein (Johnson, 1969) and it has often been suggested that inhibition of an esterase is involved with the genesis of delayed neurotoxicity. Bloch & Hottinger (1943) Earl & Thompson (1952) pointed to brain pseudocholinesterase. Both these enzymes were excluded by Davison (1953) , but Aldridge (1954) pointed out that all organophosphorus compounds producing ataxia are esters with a general capacity to inhibit esterases in vivo. Further attempts to associate delayed neurotoxicity with inhibition of particular esterases have failed (Aldridge & Barnes, 1961 , 1966 , but Aldridge's (1954) (Johnson, 1968) . Of the inhibitors mentioned frequently in this paper, DFP and mipafox produced delayed neurotoxic effects in hens and TEPP and paraoxon (diethyl 4-nitrophenyl phosphate) did not.
MATERIALS AND METHODS
Chemicals. The sources of most chemicals used were listed previously (Johnson, 1969 Bird8, do8ing and neurotoxicity testing. All details were as described before (Johnson, 1969) , except that where prophylactic treatment with oximes against the acute anticholinesterase effects of some compounds was known to be ineffective eserine (0.1 mg./kg. body wt.) was ad. ministered subcutaneously with atropine (20mg./kg.) in 0.9% NaCl 20 min. before the organophosphorus compound and no oxime reactivator was given. This variation did not affect the time of onset or severity of delayed neurotoxic symptoms produced by DFP.
Ti8&ue and buffer. Homogenates (10%, w/v) of brain were prepared in buffer by using the rotating (llOOrev./min.) smooth Perspex pestle as described by Aldridge, Emery & Street (1960) with 0-005in. difference in diameter of the tube and pestle. The buffer used for homogenization and inhibition experiments was 50mm-tris-HCl containing EDTA (0-2 mx); the pH was 8X0 determined at 200.
Assay of PPA hydrolysie in vitro. The method depends on the colorimetric determination of the liberated phenol by the method of Gottlieb & March (1946) . Homogenate (1 ml.) was incubated in centrifuge tubes for 30min. at 250 with 0-5ml. of buffer alone or buffer containing inhibitor(s). After incubation with inhibitors 2ml. of suspension of PPA in unbuffered 0.03% Triton X-100 at 200 was added; incubation was continued at 250 for 14 min. and the reaction was stopped by addition of 2ml. of 0-3m-HClO4. The tubes were cooled in ice and then centrifuged at 1500g for 20min. Then 4ml. of clear supernatant was transferred to a tube containing 2ml. of 4-aminoantipyrine (0-025% in 0-5M-tris-HCl, pH9-0); the contents were mixed and 1 ml. of aq. 0.4% KsFe(CN)s was added. The developed colour was stable for at least 1 hr. and was measured at 610nm. The PPA suspension was prepared by dissolving about 20mg.
of the ester in 2ml. of dimethylformamide and then adding Triton X-100 solution rapidly with shaking to give a final concentration of 0 33 mg. of PPA/ml. Under the conditions described liberation of phenol was linear with respect to tissue concentration and time for both inhibited and uninhibited samples.
Labelling experiments in vitro. The procedure has been described in detail previously (Johnson, 1969) ; all reactions were at 250.
Standard test for determination of the neurotoxic 8ite in vitro by radiochemical or colorimetric a88ay. The standard test for the determination of DFP-sensitive phosphorylation sites and activity ofPPA-hydrolysing enzymes relevant to delayed neurotoxicity is summarized below.
(i) Paired samples of brain homogenate were first preincubated with either (a) non-neurotoxic inhibitors (e.g. TEPP or paraoxon) or (b) mipafox plus inhibitors as in (a).
(ii) Both samples were then incubated with either [32P].
DFP to measure the quantity of remaining phosphorylation sites or with PPA to measure activity ofremaining esterases as described above. (iii) The difference between results obtained after preincubations (a) and (b) was calculated and is referred to as (a)-(b). Johnson (1969) showed that for labelling experiments (a)-(b) represents a quantity of phosphorylation sites probably associated with delayed neurotoxicity. The results of the present paper show that the difference in esterase activity measured after preincubations (a) and (b) represents an enzyme associated with delayed neurotoxicity.
For determination of the phosphorylation site the inhibi- Aldridge, 1964; Aldridge 1964 ). These workers showed that both enzymes were inhibited in vitro by low concentrations of the non-neurotoxic agents TEPP and paraoxon and were less susceptible to DFP and mipafox, which are neurotoxic. By a direct test in vivo Aldridge & Barnes (1966) showed that there was no correlation of the neurotoxic effects of a range of organophosphorus compounds with their inhibitory effect on either of these enzymes. The present finding that PPA protects the neurotoxic site in vitro has prompted a search for other PPA esterases in hen brain. Samples of brain homogenate were preincubated with various inhibitors for 30 min. and the residual PPA-hydrolysing activity was then determined. Fig. 1 shows that activity progressively decreased as paraoxon concentration was increased to 64,uM; 50% inhibition was found with about 0.6,uM-paraoxon at 250 and pH8*0 and this is in reasonable accord with the value of 0 16p&M at 370 and pH7-8 found by Poulsen & Aldridge (1964) . Fig. 1 also shows that a residue of about 10% of the total activity was barely affected by paraoxon concentrations above 64,UM, and this suggests the presence of an enzyme(s) different from those previously characterized. When TEPP (2 uM) was included in the preincubation medium the paraoxon-sensitive activity was substantially inhibited and the paraoxon-insensitive activity was not (Fig. 1) . TEPP did not inhibit the same proportion of the paraoxon-sensitive activity at all concentrations of paraoxon. This implies that the paraoxonsensitive activity is due to two or more enzymes, each with different '50 for TEPP; these are probably the two enzymes described by Poulsen & Aldridge (1964) . Fig. 2 Fig. 2 also shows that the activity sensitive to lower concentrations of TEPP (up to 64,UM) was inhibited by paraoxon (0. 5 pM) and the TEPP-insensitive activity was not.
Effect of neurotoxic inhibitor8 on the PPA-hydroly8ing activity in8en8itive to TEPP and paraoxon. Pairs of homogenate samples were preincubated with paraoxon (64 UM); one tube of each pair also contained mipafox at concentrations up to 256 pM.
After preincubation samples were assayed for PPAhydrolysing activity. It was found that about 20% of the paraoxon-insensitive activity was sensitive to mipafox ( Fig. 3) and that there was insignificant increase in inhibition at mipafox concentrations above 128 uM. Fig. 4 shows that, when the mipafoxsensitive activity was considered alone, there was a linear relationship of log (percentage activity remaining) to inhibitor concentration with the line extrapolating through log value 2-0 (±+0 001 S.D.) at zero inhibitor concentration. This shows that the mipafox-sensitive activity behaved as a single enzyme towards this inhibitor. Since the activity of (Johnson, 1969) ; the resistance to high concentrations of TEPP and paraoxon is also common to the enzyme and the neurotoxic site. With the supporting evidence that PPA blocks phosphorylation of the site, it was reasonable to postulate that the neurotoxic site was identical with the active site of the enzyme.
A standard test was used to measure this enzyme in vitro. It is analogous in principle to that used to measure the phosphorylation site associated with delayed neurotoxicity (see the Materials and Methods section), but the nature and concentration of nonneurotoxic inhibitor necessary to eliminate much irrelevant activity differs in the two tests. In order that the results of the two tests might be compared (see below) TEPP (16,UM) was included in the preincubation media (a) and (b) for esterase assay, although in practice this concentration of TEPP was found not to increase the inhibition above that caused by paraoxon (64,xM Response of the pqersoxon-ineenaitive mipafox8en8itive esteraee to admini8tration of organopho8-phorq4 compound8 in vivo. Table 1 shows the activity of PPA esterase and quantity of the neurotoxic phosphorylation site remaining in hen brain 4-24hr. after birds had been dosed with the listed compounds. In some but not all cases both determinations were carried out on the same specimen of brain. Some measurements of the phosphorylation site are quoted from Johnson (1969) . After dosage with neurotoxic compounds having a wide range of structures and physical properties both enzyme activity and quantity of phosphorylation site were markedly decreased, but they were both much less affected by non-neurotoxic analogues. This evidence, together with the ability of PPA to prevent labelling of the site by [32P]DFP in vitro, strongly supports the view that the neurotoxic phosphorylation site previously characterized is responsible for the PPA esterase activity measured in this test.
Catalytic-centre activity of the esterase. All the conditions except paraoxon concentration were identical in the determination of esterase activity and of quantity of phosphorylation site (see above).
In two separate expeuiments it was found that inclusion of paraoxon (64 uM 
DISCUSSION
The evidence presented in this paper confirms the long-standing hypothesis that inhibition of an esterase of the nervous system is an early event in the process of delayed neurotoxicity caused by organophosphorus compounds. Most of the activity of this enzyme in homogenates of whole brain was found to be inhibited after dosage with neurotoxic compounds. The enzyme in spinal cord responded similarly when tested with DFP, and it is not clear why the pathological effect is seen only in long axons. The products of the reaction normally catalysed by the 'neurotoxic' esterase may be essential nutrients, and failure of supply may manifest itself first in regions furthest removed from the neuron cell-body. Another possible function of the esterase is as a scavenger removing potentially toxic materials that initiate irreversible damage if allowed to accumulate. More understanding of the neurotoxic process may be gained by investigating metabolic reactions involving precursors or products ofthe esterase step. Recent studies with carbamates inhibiting the esterase (Johnson & Lauwerys, 1969) suggest that comparatively few variations of the chemical structure of the PPA molecule give an acceptable 'fit' at the active site. It is the more interesting therefore that two other compounds, which can be considered formally as derivatives of phenylacetic acid (see Fig. 5 ), produce delayed neurotoxic symptoms in some species and that the histological lesions are very similar to those produced by organophosphorus compounds in hens. 4-Bromophenyl isothiocyanate produces delayed ataxia in sheep (Lessel & Towlerton, 1967) and it would be possible for this compound to react directly (or via an intermediate thiocarbamate) with the active site of an esterase to give an inactive thiocarbamoylated enzyme. With 4-bromophenylacetylurea, which produces effects in rats (Cavanagh, Chen, Kyu & Ridley, 1968) , reaction with an esterase seems unlikely on chemical grounds. However, competiton at some part of an essential metabolic sequence, which could include the esterase, seems possible. In considering whether the mechanisms of delayed neurotoxicity producedby these compounds on the one hand and organophosphorus compounds on the other may be related, it is a considerable problem that no functional effects are seen when rats are given single doses of organophosphorus compounds (Barnes & Denz, 1953; Majno & Karnovsky, 1961) or when hens receive an oral dose of 4-bromophenylacetylurea (Cavanagh et al. 1968 ). More than 80% of the PPA-hydrolysing activity of hen brain has previously been shown to be due to two distinct enzymes, both very sensitive to paraoxon (Poulsen & Aldridge, 1964; Aldridge, 1964 ). The present work shows that the remaining paraoxon-insensitive activity can be subdivided into two components: about one-fifth of the activity is due to a single mipafox-sensitive enzyme associated with delayed neurotoxicity, and four-fifths is insensitive to mipafox but can be at least partially inhibited by DFP (M. K. Johnson, unpublished work) . These results demonstrate the value of irreversible inhibitors in distinguishing between enzymes having similar catalytic ability. Future investigations of the mechanisms of neurotoxicity would be greatly facilitated if a more specific substrate than PPA could be found.
Since ester substrates and carbamate inhibitors react with esterases by analogous mechanisms (Wilson, Hatch & Ginsburg, 1960; Reiner & Aldridge, 1967) , information can be gained about the specificity of the esterase by studying the effect of a variety of carbamates in the standard assay. This is more convenient than studying a variety of substrates requiring new assay procedures. Thus far no normal cell constituent has been found to be a substrate, but recent work has suggested some variations of the PPA molecular structure that may lead to increased specificity.
Preliminary attempts have been made to obtain purified preparations of the 'neurotoxic' esterase, and it may eventually be possible to carry out studies of the phosphorylation process occurring at inhibition and to devise reagents to hydrolyse the protein-phosphate bond, thus regenerating active enzyme. Such compounds might be of therapeutic value. Various oximes are known that carry out a regenerative process with inhibited acetylcholinesterase (see Heath, 1961) , but none is known to affect delayed neurotoxicity.
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